Detection of colorectal serrated polyps by stool DNA testing: Comparison with Fecal Immunochemical Testing for occult blood (FIT)

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Heigh, Russell I ^a   Yab, Tracy C ^b   Taylor, William R ^b   Hussain, Fareeda T N ^c   Smyrk, Thomas C ^b   Mahoney, Douglas W ^b   Domanico, Michael J ^d   Berger, Barry M ^d   Lidgard, Graham P ^d   Ahlquist, David A ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d Exact Sciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DNA; HEMOGLOBIN; K RAS PROTEIN; OSTEOGENIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL POLYP; COLORECTAL SERRATED POLYP; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEFECATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FECES ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD FECAL IMMUNOCHEMICAL TEST; OCCULT BLOOD TEST; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; PROTEIN METHYLATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; CHEMISTRY; COLONIC POLYPS; FECES; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROCEDURES;

AGED; COLONIC POLYPS; DNA; FECES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84916926423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085659     Document Type: Article

References (37)

1. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
2. Jass JR (2001) Serrated route to colorectal cancer: back street or super highway? J Pathol 193: 283-285.
3. Jass JR (2005) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2: 398-405.
4. Snover DC (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42: 1-10.
5. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124: 380-91. (Pubitemid 41232924)
6. Noffsinger AE (2009) Serrated polyps and colorectal cancer: new pathway to malignancy Annu Rev Pathol 4: 343-364.
7. Lazarus R, Junttila OE, Karttunen TJ, Makinen MJ (2005) The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 123: 349-359. (Pubitemid 40315075)
8. Lash RH, Genta RM, Schuler CM (2010) Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 63: 681-686.
9. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, et al. (2012) Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107: 1315-1329.
10. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, et al. (2006) High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131: 1400-1407. (Pubitemid 44708940)
11. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, et al. (2003) Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162: 815-822. (Pubitemid 36237490)
12. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, et al. (2007) Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5: 111-117. (Pubitemid 46096834)
13. Sheridan TB, Fenton H, Lewin MR, Burkart AL, Iacobuzio-Donahue CA, et al. (2006) Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act." Am J Clin Pathol 126: 564-571. (Pubitemid 44498506)
14. Oka S, Tanaka S, Hiyama T, Ito M, Kitadai Y, et al. (2004) Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc 59: 213-219. (Pubitemid 38199214)
15. Makinen MJ, George SM, Jernvall P,Makela J, Vihko P, et al. (2001) Colorectal carcinoma associated with serrated adenoma: prevalence, histological features, and prognosis. J Pathol 193: 286-294. (Pubitemid 32229858)
16. Gupta AK, Melton LJ 3rd, Petersen GM, Timmons LJ, Vege SS, et al. (2005) Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol 3: 150-158. (Pubitemid 40220310)
17. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-1633.
18. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, et al. (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366: 2345-2357.
19. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, et al. (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704-2714. (Pubitemid 39665324)
20. Ahlquist DA, Sargent DJ, Loprinzi CL,Levin TR, Rex DK, et al. (2008) Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 149: 441-450.
21. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, et al. (2005) A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129: 422-428. (Pubitemid 41096630)
22. Park DI, Ryu S, Kim YH, Lee SH, Lee CK, et al. (2010) Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 105: 2017-2025.
23. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, et al. (2010) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102: 89-95.
24. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 54: 22-30.
25. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, et al. (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150: 1-8.
26. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, et al. (2009) High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 136: 459-470.
27. Ahlquist D ZH, Domanico M, Mahoney D, Lidgard G (2010) Next generation stool DNA testing for detection of colorectal neoplasia: Early marker evaluation. Presented at AACR Meeting, Philadelphia, PA.
28. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, et al. (2012) Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 142: 248-256.
29. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, et al. (2012) The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 10: 272-277.
30. Hussain FT, Yab TC, Harrington JJ, et al. (2010) Noninvasive Detection of Serrated Colorectal Polyps by Stool Assay of Methylated Vimentin and Mutant BRAF Genes. In: DDW.
31. Lidgard GP DM, Bruinsma JJ, Light J, Gagrat ZD, Oldham-Haltom RL, et al. (2012) An Optimized Molecular Stool Test for Colorectal Cancer Screening: Evaluation of an Automated Analytic Platform and Logistic Algorithm. In: AACR Frontiers in Cancer Prevention; 2012; San Francisco, CA.
32. Lidgard GP DM, Bruinsma JJ, Gagrat ZD, Oldham-Haltom RL, Fourrier KD, et al. (2012) An optimized multi-marker stool test for colorectal cancer screening: initial clinical appraisal. Gastroenterology 142: S1.
33. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
34. Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Statist Soc B 67: 301-320. (Pubitemid 40465877)
35. Berger BM, Ahlquist DA (2012) Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 44: 80-88.
36. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK, et al. (2011) Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 9: 42-46.
37. Singh H TD, Xue L, Targownik LE, Bernstein CN (2006) Risk of Developing Colorectal Cancer Following a Negative Colonoscopy Examination: evidence for a 10-year interval between colonoscopies. JAMA 295: 2366-2373. (Pubitemid 43788104)